Yüklüyor......

Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma

The recent FDA approval of multiple new pharmaceutical agents for metastatic renal cell carcinoma (RCC) has left physicians with several options for first- and second- line therapy. With limited head-to-head comparisons, however, there is a paucity of evidence to recommend the use of one agent over...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Cancer Res
Asıl Yazarlar: Modi, Parth K., Farber, Nicholas J., Singer, Eric A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986829/
https://ncbi.nlm.nih.gov/pubmed/27540511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tcr.2016.06.05
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!